Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Davis

Showing results (61-70 of 400) with videos related to

Pageof 40
Sort By:
Analytical Biochemistry|February 1, 1971
Determination of 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) in cerebrospinal fluidS Wilk, K L Davis, S B Thacker
Neurobiology of Aging|September 1, 1986
Antemortem markers of Alzheimer's diseaseE Hollander, R C Mohs, K L Davis
Progress in Brain Research|January 1, 1990
Implications of multiple transmitter system lesions for cholinomimetic therapy in Alzheimer's diseaseV Haroutunian, A C Santucci, K L Davis
Brain Research|September 4, 1989
Interactions of forebrain cholinergic and somatostatinergic systems in the ratV Haroutunian, P D Kanof, K L Davis
British Medical Bulletin|January 1, 1986
Cholinergic approaches to the treatment of Alzheimer's diseaseE Hollander, R C Mohs, K L Davis
Brain Research|October 29, 1986
Partial reversal of lesion-induced deficits in cortical cholinergic markers by nerve growth factorV Haroutunian, P D Kanof, K L Davis
Clinical and Experimental Immunology|November 1, 1986
Induction of interleukin 2 receptors on immature human thymocytes and co-expression of T3 and T6 antigensG H Reem, K L Davis, S Carding
Biological Psychiatry|February 1, 1982
Rapid antidepressant activity of melanocyte-inhibiting factor: a clinical trialM I Levy, Y DeNigris, K L Davis
Journal of Consulting and Clinical Psychology|August 1, 1977
Development of an Institutionalized Chronic Alcoholic ScaleJ P Atsaides, C Neuringer, K L Davis
Brain Research|May 15, 1989
Attenuation of nucleus basalis of Meynert lesion-induced cholinergic deficits by nerve growth factorV Haroutunian, P D Kanof, K L Davis
Pageof 40

Showing results (61-70 of 400) with videos related to

Sort By:
Pageof 40
Analytical Biochemistry|February 1, 1971
Determination of 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) in cerebrospinal fluidS Wilk, K L Davis, S B Thacker
Neurobiology of Aging|September 1, 1986
Antemortem markers of Alzheimer's diseaseE Hollander, R C Mohs, K L Davis
Progress in Brain Research|January 1, 1990
Implications of multiple transmitter system lesions for cholinomimetic therapy in Alzheimer's diseaseV Haroutunian, A C Santucci, K L Davis
Brain Research|September 4, 1989
Interactions of forebrain cholinergic and somatostatinergic systems in the ratV Haroutunian, P D Kanof, K L Davis
British Medical Bulletin|January 1, 1986
Cholinergic approaches to the treatment of Alzheimer's diseaseE Hollander, R C Mohs, K L Davis
Brain Research|October 29, 1986
Partial reversal of lesion-induced deficits in cortical cholinergic markers by nerve growth factorV Haroutunian, P D Kanof, K L Davis
Clinical and Experimental Immunology|November 1, 1986
Induction of interleukin 2 receptors on immature human thymocytes and co-expression of T3 and T6 antigensG H Reem, K L Davis, S Carding
Biological Psychiatry|February 1, 1982
Rapid antidepressant activity of melanocyte-inhibiting factor: a clinical trialM I Levy, Y DeNigris, K L Davis
Journal of Consulting and Clinical Psychology|August 1, 1977
Development of an Institutionalized Chronic Alcoholic ScaleJ P Atsaides, C Neuringer, K L Davis
Brain Research|May 15, 1989
Attenuation of nucleus basalis of Meynert lesion-induced cholinergic deficits by nerve growth factorV Haroutunian, P D Kanof, K L Davis
Pageof 40